Laura Brege, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 10,000 shares at $73.57 ($738K) on 2014-05-09, disclosed to the SEC on 2014-05-09.
Scheduled sale ($738k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.57 | 7,500 | $552K | 74.7% |
| 2 | $74.67 | 2,500 | $187K | 25.3% |
| Total | $73.84 avg | 10,000 | $738K | 100% |
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |